Crizanlizumab does not affect mortality or the number of days free of respiratory or cardiovascular (CV) organ-support measures in hospitalized patients with COVID-19. A humanized monoclonal antibody ...
In a surprising discovery, a ‘sticky molecule’ that occurs naturally in our blood vessels could be both a culprit behind blood clots and organ failure during COVID and long COVID and the key to new ...
In a surprising discovery, a 'sticky molecule' that occurs naturally in our blood vessels could be both a culprit behind blood clots and organ failure during COVID and long COVID and the key to new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results